SPAR (Skin Products Assessment Research)
The Skin Products Assessment Research (SPAR) Study is a multi-center, double-blind, randomized, controlled study to investigate the effects of the Obagi Nu-Derm System (ONDS) before and after chemical peel or ablative laser resurfacing in healthy adult female volunteers. ONDS will be compared to a standard care regimen before and after either chemical peel or laser.
This study includes patients who have photodamage and/or rhytids. SPAR is being conducted under the direction of study co-principal investigators Ed Wilkins, MD, MS and Andrea Pusic, MD, MS.
Support of this research is provided by The Plastic Surgery Foundation and Obagi Medical Products.